Disease | infantile neuroaxonal dystrophy |
Comorbidity | C1140680|ovarian cancer |
Sentences | 1 |
PubMedID- 20092424 | The phase iii development plan in ovarian cancer patients includes combination chemotherapy studies in both platinum-sensitive (recently launched) and platinum-resistant (planned) recurrent disease. |
Page: 1